Margins soar, revenue stalls — management bets H2 delivers the quarter's growth
S.P. Apparels posted PAT up 20.4% YoY on margin expansion, but revenue flat at ₹401 Cr. Guidance for ₹2,000 Cr FY27 maintained without upgrade. The market has priced in skepticism: stock down 12.77% by day 3. Everything hinges on unbooked H2 growth.
₹401.1 Cr
-0.6% YoY | +9.9% QoQ
₹24.9 Cr
+20.4% YoY | +33.8% QoQ
17.6%
+230 bps YoY
15.3%
+220 bps YoY
The profit-growth story is real, but it masks a deeper problem: S.P. Apparels delivered earnings expansion without revenue growth. PAT rose 20.4% YoY while revenue stayed flat. That tells you the quarter was driven by margin mix and efficiency, not volume — the opposite of what the ₹2,000 Cr FY27 guidance needs.
Where the profit came from: operational excellence, not growth
The garment division's EBITDA margin expanded 230 basis points to 17.6% despite utilization dropping 14% YoY (due to 750 new machines added in FY27 diluting the base). Management attributed the flat revenue to tariff-driven order slowness in Jan–May 2026, not operational stumble. That's credible: the order book stands at ₹570 Cr covering 4–5 months at planned run rate, and management detailed exactly which customers withheld orders awaiting tariff clarity (not a container crunch or facility issue). Standalone adjusted EBITDA margin (ex one-time ₹1.75 Cr forex impact in packing credit) was 17.5%, suggesting the earnings quality is sustainable.
However, profits grew while revenue was flat. That margin story is powerful for a quarter, but it's not a growth story. And guidance of ₹2,000 Cr FY27 requires growth—specifically, H2 to deliver nearly ₹600+ Cr more than H1 to hit the target. The company reaffirmed this guidance without raising it, which is telling: management is confident but not overextending.
Q1 profitability improved meaningfully
PAT +20.4% YoY to ₹24.9 Cr; EBITDA margin 15.3% vs 13.1% prior year
Supported
₹2,000 Cr FY27 guidance is achievable
Q1 ₹401 Cr flat YoY; order book ₹570 Cr covers 4–5 months; H2 unbooked but management confident
Partially corroborated — requires H2 delivery
Margins driven by efficiency and product mix, not one-offs
Garment EBITDA 17.6% despite lower utilization; ₹1.75 Cr forex loss normalized away
Supported
Sri Lanka facility operationally on track by end-FY27
₹25 Cr Q1 revenue, 1,650 machines at 85–90% capacity, projected ₹150–200 Cr FY-end
On track but still integration phase
SPUK +125% YoY growth demonstrates traction
₹33.3 Cr revenue (+125% YoY); EBITDA negative ₹1.04 Cr due to air freight and timing
Supported on volume; profitability deferred
What changed on this call
Three upgrades to the forward story: (1) Marks & Spencer signed for SPUK sourcing, anchoring the U.K. retail/trading arm with a marquee customer and multi-year volumes; (2) Sri Lanka facility ramp visible — ₹25 Cr Q1 revenue with ₹150–200 Cr FY-end guidance (6–8x growth in three quarters) replaces prior concept stage; (3) Order book disclosed for the first time — ₹570 Cr total (SPAL ₹430 Cr, Young Brand ₹100 Cr, SPUK ₹70 Cr) provides transparency on near-term revenue visibility. Young Brand facilities expected online by October; bra product capex capped at ₹10 Cr max. The company also quantified tariff drag, pinpointing Jan–May 2026 as the period of customer order delays and confirming no spillover expected into Q2.
The guidance bet: everything rides on H2 execution
Reaffirmed FY27 consolidated revenue of ₹2,000 Cr, with specific segment targets: SPAL infant export ₹1,300–1,400 Cr (18–27% growth), Young Brand ₹340–350 Cr (13–17% growth), SPUK GBP 13M in three years (currently ₹33 Cr), Sri Lanka ₹150–200 Cr. Consolidated EBITDA margin guided for 14–15% full year. On paper, the targets look disciplined. In practice, the order book of ₹570 Cr covers only 4–5 months of run rate, leaving roughly 7–8 months of H2 unbooked. Management is betting that tariff rollback (underway) and FTA benefits (U.K. live, EU expected by year-end) will unlock sufficient customer orders to close the gap. This is a conviction play, not a hedge.
Garment EBITDA 17.6% despite capacity dilution proves operational edge
Marks & Spencer anchor customer de-risks SPUK scaling
Order book ₹570 Cr covers only 4–5 months; H2 unbooked
SPUK EBITDA negative ₹1.04 Cr; Retail barely breakeven; Sri Lanka pre-operative losses
FY27 guidance maintained without upgrade, suggesting prudence or lack of confidence
Tariff benefit dependent on external catalysts (reversal, FTA timing) outside company control
Management tone confident, numbers specific, no deflection on execution
Capex heavy (₹100+ Cr FY27); returns delayed; multi-year payoff uncertain
The street's read: skepticism priced in
The market has delivered its own verdict: stock down 12.77% by day 3 post-result announcement, compared to pre-result close of ₹1,074.5. This is not a routine profit-warning decline—it's a structural dismissal. At ₹932.45 (as of Aug 17), the stock sits 23.69% below its all-time high of ₹1,221.9, yet 55.41% above its 52-week low. Technicals are mixed: price below SMA20 and SMA50 (near-term weakness) but above SMA200 (longer-term uptrend intact). RSI at 42.5 is neutral, not oversold—there's room to run either direction.
Ownership flows confirm the skepticism: DII holdings declined 42 basis points QoQ (from 16.57% to 16.15%), while FII holdings remained flat at 1.49%. Promoters unchanged at 61.81%. The DII selling into profit growth is notable—institutional investors don't believe the H2 story. No bulk or insider selling signals alarm (largest recent trades were NK Securities buying and selling in June at ₹896–897 per share, well below current price), but the absence of buying pressure is telling.
Valuation: At current price, the stock is down from the highs but no longer in free fall. If H2 delivers ₹600+ Cr growth and ₹2,000 Cr FY27 is achieved, the street will re-rate the stock sharply upward (likely back to ₹1,100+). If H2 orders don't flow and guidance is missed, the stock re-tests ₹700–800. The risk-reward is binary, not balanced.
H2 orders not flowing; ₹2,000 Cr guidance missed
HighUnbooked H2 (7–8 months of the 6-month half) must deliver ₹600+ Cr to hit target. If tariff reversal stalls or FTA delays, customer orders won't materialize. Guidance miss triggers sharp re-rating.
U.S. tariff bill reversal uncertain; orders booked only till Jan 2027
HighJan–May 2026 drag attributed to tariff uncertainty; customers holding back. New tariff bill passed Congress with unclear implementation. If reversal stalls, Young Brand (100% U.S. market) and SPAL customers delay fresh orders.
SPUK profitability deferred; cash burn masked by top-line growth
MediumSPUK EBITDA negative ₹1.04 Cr on ₹33.3 Cr revenue. Management says timing/air freight one-time, but underlying trading model has thin margins. Scale to GBP 50M (5-year target) requires flawless execution.
Sri Lanka integration ongoing; pre-operative losses persist
Medium₹25 Cr Q1 revenue with pre-operative losses; expected to normalize by March. Ramp to ₹150–200 Cr FY-end is aggressive (6–8x growth in 3Q). If integration stumbles or cost control slips, losses extend into FY28.
Execution on ₹10k-machine capacity expansion + Young Brand ramp + bra product launch
MediumMultiple moving parts in parallel. Capex heavy (₹100+ Cr FY27). Returns delayed. Any one failure (delayed facility opening, bra product flop, equipment issue) cascades into revenue miss.
EU-India FTA signing delayed; expected end-FY27 but timing uncertain
Low–MediumFTA benefit is a tailwind, not a dependency. Delay slips upside into FY28 but doesn't derail core SPAL growth. Lower severity because tariff reversal benefit already priced into Q1–Q2 orders.
1 · Q2 revenue vs. Q1: the tariff reversal test
Management guided for Q2 to be better than Q1. Tariff reversal benefit should flow through in order book. If Q2 is flat or lower than Q1 (₹401 Cr), the H2 bet collapses. Watch the SPAL infant export segment specifically—this is where tariff upside lives.
2 · Order book update and customer traction
By Oct–Nov, watch for management commentary on new orders received. Marks & Spencer first shipment is a key milestone. 3 new U.K./EU brands must begin shipments. If order pipeline slows or new customers stall, H2 growth is at risk.
3 · Young Brand facilities online by Oct; bra product ramp Dec onward
Capacity coming online but demand must follow. Monitor Young Brand revenue and margin. Bra product launch is a new SKU upside but carries execution risk. Full production FY28.
4 · FTA timing: U.K. live, EU by year-end
U.K. FTA is already in effect; EU expected by end-FY27. Watch for new customer wins and order inflows from EU-sourced brands. FTA is a structural tailwind but its magnitude and timing are variable.
5 · Sri Lanka revenue tracking ₹150–200 Cr FY-end
Q1 delivered ₹25 Cr. Q2–Q4 combined must deliver ₹125–175 Cr for management guidance to hold. Monitor utilization, capex, and pre-operative losses. By March 2027, Sri Lanka should reach self-sustainability (management target).
S.P. Apparels has proven operational excellence—a 230 basis point margin expansion while revenue stayed flat is not accidental. But operational excellence is not the same as growth delivery. The quarter was about mix and efficiency; FY27 guidance requires volume growth, and H2 is now carrying a full year's growth target on its own shoulders.
The company is not dishonest about the risk. Management reaffirmed guidance without raising it, disclosed the order book for the first time, quantified tariff drag, and backed up claims with specific numbers (Marks & Spencer, ₹570 Cr order book, facilities coming online by October). The tone is confident but realistic. However, the market has translated this into skepticism: DII is selling, and the stock is down 23% from ATH. That's not irrational—it's the street's way of saying 'prove the H2 story first.'
The valuation is now interesting. At ₹932 (55% above the 52-week low), the stock offers a trade-off: If H2 delivers ₹600+ Cr growth and guidance holds, expect a sharp re-rate to ₹1,100+. If orders don't flow and guidance is missed, expect a retest of ₹700–800. This is binary, not a steady-state hold.
The number to track from here is Q2 revenue. It's the canary in the coal mine. If Q2 is better than Q1 (₹401 Cr) and trending toward ₹450+ Cr, the H2 story gains traction. If Q2 is flat or lower, the guidance unravels and the stock re-rates down. Everything else—order book, facilities, new customers—flows from whether the order flow actually accelerates. The operational excellence is proven; the growth bet is not.
Informational and educational content only. Not investment advice.